Guanosine-5-triphosphate disodium salt
CAS No. 56001-37-7
Guanosine-5-triphosphate disodium salt( 5'-GTP disodium salt )
Catalog No. M26240 CAS No. 56001-37-7
Guanosine-5'-triphosphate disodium salt is an enhancer of myogenic cell differentiation and an energy source for translation and other important cellular processes.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
200MG | 31 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGuanosine-5-triphosphate disodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionGuanosine-5'-triphosphate disodium salt is an enhancer of myogenic cell differentiation and an energy source for translation and other important cellular processes.
-
DescriptionGuanosine-5'-triphosphate disodium salt is an enhancer of myogenic cell differentiation and an energy source for translation and other important cellular processes.
-
In Vitro——
-
In Vivo——
-
Synonyms5'-GTP disodium salt
-
PathwayOthers
-
TargetOther Targets
-
RecptorBAZ1A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56001-37-7
-
Formula Weight567.144
-
Molecular FormulaC10H14N5Na2O14P3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (220.40 mM)
-
SMILES[Na+].[Na+].Nc1nc2n(cnc2c(=O)[nH]1)C1OC(COP([O-])(=O)OP(O)(=O)OP(O)([O-])=O)C(O)C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tecovirimat
Tecovirimat (ST-246, Tpoxx) is a potent, orally bioavailable, first-in-class inhibitor of orthopoxvirus egress with EC50 of 0.01-0.6 uM against a panel of Orthopoxvirusesu.
-
LSKL(a)
LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
-
trans-2-Butene-14-di...
3-Hexenedioic acid is a normal human unsaturated dicarboxylic acid metabolite with increased excretion in patients with Dicarboxylic aciduria caused by fatty acid metabolism disorders The urinary excretion of 3-Hexenedioic acid is increased in conditions of augmented mobilization of fatty acids or inhibited fatty acid oxidation.